SCHEMBL2710000

SCHEMBL2710000

CCCCCCCC/C=C/CCCCCCCC(=O)OC(CO)CO

nearest known ligand 0.83

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.83
FAAH O00519 1/20 0.83
ALDH1A1 P00352 1/20 0.83
HPGD P15428 1/20 0.83
CNR1 P21554 1/20 0.83
CNR2 P34972 1/20 0.83
PRKCA P17252 3/20 0.81
PRKCE Q02156 2/20 0.81
PRKCQ Q04759 2/20 0.81
PRKCD Q05655 2/20 0.81
MAPK1 P28482 1/20 0.81
S1PR1 P21453 1/20 0.68
DGKA P23743 1/20 0.62
SLC6A5 Q9Y345 1/20 0.61
DAGLA Q9Y4D2 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16172 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL9775032 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL18632787 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL662601 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL19756819 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL30454466 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL30863748 1.00 MAPT (0.83) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL14856360 0.98 MAPT (0.81) MAPTFAAHALDH1A1HPGDCNR1
SCHEMBL10709380 0.98 MAPT (0.81) MAPTFAAHALDH1A1HPGDCNR1
Ethylene SCHEMBL6976654 0.97 MAPT (0.78) MAPTFAAHALDH1A1HPGDCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4451879-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF Apeel Technology, Inc. (US) 2024-10-30 EP disclosed
WO-2023122793-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF APEEL TECHNOLOGY, INC. (US) 2023-06-29 WO disclosed
US-20230200405-A1 METHODS FOR ISOLATING ANTIMICROBIAL MICROORGANISMS FROM AGRICULTURAL PRODUCTS AND USES THEREOF APEEL TECHNOLOGY, INC. 2023-06-29 US disclosed
EP-4129062-A1 METHOD FOR FORMING A PROTECTIVE COATING BY APPLYING FATTY ACID GLYCERIDE COMPOUNDS TO A SURFACE Apeel Technology, Inc. (US) 2023-02-08 EP disclosed
EP-3649860-B1 PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS APEEL TECH INC (US) 2023-02-01 EP disclosed
EP-3349589-B1 METHOD FOR FORMING A PROTECTIVE COATING BY APPLYING FATTY ACID GLYCERIDE COMPOUNDS TO A SURFACE APEEL TECH INC (US) 2022-12-14 EP disclosed
EP-3649860-A1 PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS Apeel Technology, Inc. (US) 2020-05-13 EP disclosed
US-20170332650-A1 METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS APEEL TECHNOLOGY, INC. 2017-11-23 US disclosed
WO-2017172951-A1 METHOD OF REDUCING SPOILAGE IN HARVESTED PRODUCE DURING STORAGE AND SHIPPING APEEL TECHNOLOGY, INC. (US) 2017-10-05 WO disclosed
WO-2017100636-A1 PLANT EXTRACT COMPOSITIONS FOR FORMING PROTECTIVE COATINGS APEEL TECHNOLOGY, INC. (US) 2017-06-15 WO disclosed
WO-2017048951-A1 PRECURSOR COMPOUNDS FOR MOLECULAR COATINGS APEEL TECHNOLOGY, INC. (US) 2017-03-23 WO disclosed
US-20170073532-A1 Precursor compounds for molecular coatings APEEL TECHNOLOGY, INC. 2017-03-16 US disclosed
US-20160102166-A1 NATURAL OIL POLYOLS DERIVED FROM POST-CONSUMER RECYCLE OILS JOHNSON CONTROLS TECHNOLOGY COMPANY (US) 2016-04-14 US disclosed
US-20120128770-A1 TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE KOBENHAVNS UNIVERSITET (DK) 2012-05-24 US disclosed
EP-2445494-A1 TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE Københavns Universitet (DK) 2012-05-02 EP disclosed
WO-2010149170-A1 TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE Københavns Universitet (DK) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120128770-A1 TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE GPR119, GLP1R, GCGR MAPT 4863/4885FAAH 213/4885ALDH1A1 2423/4885
US-20160102166-A1 NATURAL OIL POLYOLS DERIVED FROM POST-CONSUMER RECYCLE OILS PUF60, MGLL, PHOSPHO1 MAPT 1908/4885FAAH 590/4885ALDH1A1 4095/4885
US-20170332650-A1 METHOD FOR PREPARING AND PRESERVING SANITIZED PRODUCTS TET2, SI, CAT MAPT 3138/4885FAAH 745/4885ALDH1A1 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.